Wearable, Luminescent Oxygen Sensor for Transcutaneous Oxygen Monitoring

2018 ◽  
Vol 10 (48) ◽  
pp. 41026-41034 ◽  
Author(s):  
Chang-Jin Lim ◽  
Soyeon Lee ◽  
Jin-Hoon Kim ◽  
Hye-Jun Kil ◽  
Yu-Chan Kim ◽  
...  
2003 ◽  
Vol 95 (1-3) ◽  
pp. 373-377 ◽  
Author(s):  
Kohji Mitsubayashi ◽  
Yoshihiko Wakabayashi ◽  
Daisuke Murotomi ◽  
Takua Yamada ◽  
Tatsuya Kawase ◽  
...  

PEDIATRICS ◽  
1979 ◽  
Vol 63 (3) ◽  
pp. 504-505
Author(s):  
Michael H. Malloy ◽  
Frank H. Morriss ◽  
Eugene W. Adcock ◽  
Susan E. Denson

As participants in the clinical field trials in the United States for the Roche 5301 transcutaneous oxygen monitor, we report here the results of our experience for comparison with that reported by Meith and colleagues in an earlier Letter (Pediatrics 58: 299, August 1976). The Roche model 5301 differs from the previously tested model 5300 in that the oxygen sensor has been modified and the electrode operates at 44 C instead of 42 C. Thirty-two newborn infants of 28 to 39 weeks' gestational age and 560 to 3,700 gm birth weight were monitored while they experienced respiratory illness caused by idiopathic respiratory distress syndrome, pneumonia, or apnea.


1990 ◽  
Vol 57 (1) ◽  
pp. 47-52
Author(s):  
Sikander Adeni ◽  
D. Vidyasagar

1984 ◽  
Vol 12 (2) ◽  
pp. 121-124 ◽  
Author(s):  
HOWARD W. KILBRIDE ◽  
GERALD B. MERENSTEIN

1983 ◽  
Vol 5 (1) ◽  
pp. 5-12
Author(s):  
Marykay Pasnick ◽  
Jerold F. Lucey

The comparison between intermittent Pao2 samples and a continuous transcutaneous PO2 recording can be compared to viewing a sports event by means of a single black and white photograph taken during the game versus a televised version complete with instant replays. Transcutaneous monitoring has made it possible to visualize the immediate effect of therapeutic maneuvers on PO2 as well as the physiologic response to a variety of routine procedures. In certain clinical situations with circulatory compromise, this measurement of tissue oxygenation may be a more pertinent clinical parameter than Pao2. The ability to monitor transcutaneous O2 tension continuously should enable researchers to further unravel the relationship of Po2 to various neonatal disorders such as retinopathy of prematurity, bronchopulmonary dysplasia, and intraventricular hemorrhage. Other physiologic parameters may also be measured transcutaneously. A transcutaneous Pco2 monitor is now in use clinically, and a transcutaneous pH electrode, still in the developmental process, should be available in the near future. Like the transcutaneous Po2 monitor, these devices generate a continuous flow of clinical data enabling nurses and physicians to make rapid informed decisions based on the patient's current physiologic status.


1983 ◽  
Vol 22 (6) ◽  
pp. 431-435 ◽  
Author(s):  
William C. L. Yip ◽  
John S. H. Tay ◽  
H.B. Wong ◽  
T.F. Ho

1981 ◽  
Vol 6 (2) ◽  
pp. 156-160
Author(s):  
DAVID J. HARRY ◽  
GARY GRAHAM ◽  
BRIAN DAVISON ◽  
MARGARET KENNY

Sign in / Sign up

Export Citation Format

Share Document